Eulàlia Grau

SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity

Benjamin Trinité, Ferran Tarrés-Freixas, Jordi Rodon et al. · Scientific Reports · 2021 · 123 citations · Full text

Measurement of Intracellular Didanosine and Tenofovir Phosphorylated Metabolites and Possible Interaction of the Two Drugs in Human Immunodeficiency Virus-Infected Patients

Alain Pruvost, Eugènia Negredo, Henri Bénech et al. · Antimicrobial Agents and Chemotherapy · 2005 · 111 citations · Full text

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

Andrea Alemany, Pere Millat-Martínez, Marc Corbacho‐Monné et al. · The Lancet Respiratory Medicine · 2022 · 84 citations · Full text

Covid-19 Pandemic, Clinical Trials, Treatment Option +5

Rate and predictors of progression in elite and viremic HIV-1 controllers

Agathe León, Ignacio Pérez, Ezequiel Ruíz-Mateos et al. · AIDS · 2016 · 82 citations

ZNRD1 (Zinc Ribbon Domain–Containing 1) Is a Host Cellular Factor That Influences HIV‐1 Replication and Disease Progression

Ester Ballana, Jordi Senserrich, Eduardo Pauls et al. · Clinical Infectious Diseases · 2010 · 48 citations · Full text